<?xml version="1.0" encoding="UTF-8"?>
<ref id="B2" class="ref">
 <mixed-citation publication-type="journal" class="mixed-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Astolfi</surname>
    <given-names class="given-names">A.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Felicetti</surname>
    <given-names class="given-names">T.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Iraci</surname>
    <given-names class="given-names">N.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Manfroni</surname>
    <given-names class="given-names">G.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Massari</surname>
    <given-names class="given-names">S.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Pietrella</surname>
    <given-names class="given-names">D.</given-names>
   </name>
   <etal class="etal"/>
  </person-group> (
  <year class="year">2017</year>). 
  <article-title class="article-title">Pharmacophore-based repositioning of approved drugs as novel 
   <italic class="italic">Staphylococcus aureus</italic> NorA efflux pump inhibitors.
  </article-title>
  <source class="source">
   <italic class="italic">J. Med. Chem.</italic>
  </source>
  <volume class="volume">60</volume>
  <fpage class="fpage">1598</fpage>â€“
  <lpage class="lpage">1604</lpage>. 
  <pub-id pub-id-type="doi" class="pub-id">10.1021/acs.jmedchem.6b01439</pub-id>
  <?supplied-pmid 28117588?>
  <pub-id pub-id-type="pmid" class="pub-id">28117588</pub-id>
 </mixed-citation>
</ref>
